These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 3700585
1. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. Fisher EC, Nelson ME, Frontera WR, Turksoy RN, Evans WJ. J Clin Endocrinol Metab; 1986 Jun; 62(6):1232-6. PubMed ID: 3700585 [Abstract] [Full Text] [Related]
2. Exercise-induced stress responses of amenorrheic and eumenorrheic runners. Loucks AB, Horvath SM. J Clin Endocrinol Metab; 1984 Dec; 59(6):1109-20. PubMed ID: 6436286 [Abstract] [Full Text] [Related]
3. Hypergonadotropic amenorrhea and bone density: new approach to an old problem. Devleta B, Adem B, Senada S. J Bone Miner Metab; 2004 Dec; 22(4):360-4. PubMed ID: 15221495 [Abstract] [Full Text] [Related]
4. Diet and bone status in amenorrheic runners. Nelson ME, Fisher EC, Catsos PD, Meredith CN, Turksoy RN, Evans WJ. Am J Clin Nutr; 1986 Jun; 43(6):910-6. PubMed ID: 3717065 [Abstract] [Full Text] [Related]
5. Bone density in amenorrheic women with and without hyperprolactinemia. Schlechte JA, Sherman B, Martin R. J Clin Endocrinol Metab; 1983 Jun; 56(6):1120-3. PubMed ID: 6404918 [Abstract] [Full Text] [Related]
9. Decreased spinal mineral content in amenorrheic women. Cann CE, Martin MC, Genant HK, Jaffe RB. JAMA; 1984 Feb 03; 251(5):626-9. PubMed ID: 6690836 [Abstract] [Full Text] [Related]
10. Bone mineral density after resumption of menses in amenorrheic athletes. Drinkwater BL, Nilson K, Ott S, Chesnut CH. JAMA; 1986 Jul 18; 256(3):380-2. PubMed ID: 3723725 [Abstract] [Full Text] [Related]
11. Exaggerated gonadotropin response to luteinizing hormone-releasing hormone in amenorrheic runners. Yahiro J, Glass AR, Fears WB, Ferguson EW, Vigersky RA. Am J Obstet Gynecol; 1987 Mar 18; 156(3):586-91. PubMed ID: 3548381 [Abstract] [Full Text] [Related]
12. Evidence for increased dopaminergic and opioid activity in patients with hypothalamic hypogonadotropic amenorrhea. Quigley ME, Sheehan KL, Casper RF, Yen SS. J Clin Endocrinol Metab; 1980 May 18; 50(5):949-54. PubMed ID: 6246138 [Abstract] [Full Text] [Related]
13. Low bone mass density at multiple skeletal sites, including the appendicular skeleton in amenorrheic runners. Pettersson U, Stålnacke B, Ahlénius G, Henriksson-Larsén K, Lorentzon R. Calcif Tissue Int; 1999 Feb 18; 64(2):117-25. PubMed ID: 9914318 [Abstract] [Full Text] [Related]
18. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V. J Clin Endocrinol Metab; 1988 Jul 18; 67(1):124-30. PubMed ID: 3379129 [Abstract] [Full Text] [Related]
19. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. J Clin Invest; 1976 May 18; 57(5):1320-9. PubMed ID: 770505 [Abstract] [Full Text] [Related]
20. Menstrual function and bone mass in elite women distance runners. Endocrine and metabolic features. Marcus R, Cann C, Madvig P, Minkoff J, Goddard M, Bayer M, Martin M, Gaudiani L, Haskell W, Genant H. Ann Intern Med; 1985 Feb 18; 102(2):158-63. PubMed ID: 3966752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]